Skip to main content
DAE HWA PHARM CO., LTD logo

DAE HWA PHARM CO., LTD — Investor Relations & Filings

Ticker · 067080 ISIN · KR7067080002 KO Manufacturing
Open in API
Filings indexed 444 across all filing types
Latest filing 2025-02-14 Notice of Dividend Amou…
Country KR South Korea
Listing KO 067080

About DAE HWA PHARM CO., LTD

http://www.dhpharm.co.kr

DAE HWA PHARM CO., LTD. is a pharmaceutical company focused on the research, development, and manufacturing of finished drug products. The company's core competency lies in its advanced Drug Delivery System (DDS) technologies, particularly its proprietary lipid-based self-emulsifying platform, DHLASED. This technology enabled the development of Liporaxel®, the world's first approved oral formulation of the anticancer agent paclitaxel. The company's portfolio also includes analgesics and anti-inflammatory drugs, such as the LOXONA trans-dermal patch, as well as aesthetic products like hyaluronic acid fillers and consumer health solutions.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from '대화제약' (Daehwa Pharmaceutical) regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date (2024-12-31), and the board resolution date (2025-02-14). This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2025-02-14 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Korean Financial Supervisory Service (FSS). It details changes in share ownership and collateral agreements by major shareholders of Daewha Pharmaceutical Co., Ltd. This type of filing is a standard regulatory disclosure regarding significant shareholding thresholds and changes in ownership structure, which falls under the 'Major Shareholding Notification' category.
2025-02-07 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a regulatory filing in South Korea required under the Capital Markets Act when a person or entity acquires a significant stake (typically 5% or more) in a listed company. This specific document is a correction (정정신고) to a previously filed report regarding changes in shareholding and collateral contracts. This falls under the 'Major Shareholding Notification' category.
2025-02-07 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership, including specific transaction dates, quantities, and the purpose of holding (management influence). The document explicitly mentions it is a '정정신고' (Correction Report) regarding previous filings. This falls under the category of Major Shareholding Notification.
2025-02-07 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a regulatory filing in South Korea required when an individual or entity acquires a significant stake (typically 5% or more) in a company. The document explicitly mentions '정정신고' (Correction Report) and provides detailed tables regarding shareholding changes, special relationships, and collateral contracts. This falls under the category of Major Shareholding Notification.
2025-02-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the shareholding status, changes in shareholding, and collateral agreements (stock-backed loans) of major shareholders and their special related parties. This falls under the category of 'Major Shareholding Notification' (MRQ) as it tracks significant ownership levels and changes in control-related holdings.
2025-02-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.